NeurAxon
Toronto · Founded 2004
About NeurAxon
NeurAxon, discovers and develops pain therapeutics targeting neuronal nitric oxide synthase. It has oral products in pipeline addressing acute migraine, neuropathic pain chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. The company was founded in 2004 and is headquartered in Toronto, Canada.
Company Facts
- Founded: 2004
- Legal name: NeurAxon Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $57.4M
- Last round: Series Unknown (May 2012)
- Website: neuraxon.com
- Phone: +1 416-673-6697
Social Profiles
Canonical: https://fsome.com/organization/neuraxon-8370211 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.